BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11063574)

  • 1. Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex.
    Schiering N; Casale E; Caccia P; Giordano P; Battistini C
    Biochemistry; 2000 Nov; 39(44):13376-82. PubMed ID: 11063574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and biophysical investigation of the interaction of a mutant Grb2 SH2 domain (W121G) with its cognate phosphopeptide.
    Papaioannou D; Geibel S; Kunze MB; Kay CW; Waksman G
    Protein Sci; 2016 Mar; 25(3):627-37. PubMed ID: 26645482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRB2 dimerization mediated by SH2 domain-swapping is critical for T cell signaling and cytokine production.
    Sandouk A; Xu Z; Baruah S; Tremblay M; Hopkins JB; Chakravarthy S; Gakhar L; Schnicker NJ; Houtman JCD
    Sci Rep; 2023 Mar; 13(1):3505. PubMed ID: 36864087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of the SH2 domain of Grb2/Ash complexed with EGF receptor-derived phosphotyrosine-containing peptide.
    Tsuchiya S; Ogura K; Hatanaka H; Nagata K; Terasawa H; Mandiyan V; Schlessinger J; Aimoto S; Ohta H; Inagaki F
    J Biochem; 1999 Jun; 125(6):1151-9. PubMed ID: 10348919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.
    Stein EG; Ghirlando R; Hubbard SR
    J Biol Chem; 2003 Apr; 278(15):13257-64. PubMed ID: 12551896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and energetic aspects of Grb2-SH2 domain-swapping.
    Benfield AP; Whiddon BB; Clements JH; Martin SF
    Arch Biochem Biophys; 2007 Jun; 462(1):47-53. PubMed ID: 17466257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution crystal structure of the Grb2 SH2 domain with a phosphopeptide derived from CD28.
    Higo K; Ikura T; Oda M; Morii H; Takahashi J; Abe R; Ito N
    PLoS One; 2013; 8(9):e74482. PubMed ID: 24098653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for specificity switching of the Src SH2 domain.
    Kimber MS; Nachman J; Cunningham AM; Gish GD; Pawson T; Pai EF
    Mol Cell; 2000 Jun; 5(6):1043-9. PubMed ID: 10911998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain.
    Schoepfer J; Gay B; Caravatti G; Garcia-Echeverria C; Fretz H; Rahuel J; Furet P
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2865-70. PubMed ID: 9873638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
    Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
    J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the mammalian Grb2 adaptor.
    Maignan S; Guilloteau JP; Fromage N; Arnoux B; Becquart J; Ducruix A
    Science; 1995 Apr; 268(5208):291-3. PubMed ID: 7716522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2.
    Lemmon MA; Ladbury JE; Mandiyan V; Zhou M; Schlessinger J
    J Biol Chem; 1994 Dec; 269(50):31653-8. PubMed ID: 7527391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain.
    Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
    J Biomol NMR; 1997 Oct; 10(3):273-8. PubMed ID: 9390405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pH and salt bridges on structural assembly: molecular structures of the monomer and intertwined dimer of the Eps8 SH3 domain.
    Kishan KV; Newcomer ME; Rhodes TH; Guilliot SD
    Protein Sci; 2001 May; 10(5):1046-55. PubMed ID: 11316885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2.
    McNemar C; Snow ME; Windsor WT; Prongay A; Mui P; Zhang R; Durkin J; Le HV; Weber PC
    Biochemistry; 1997 Aug; 36(33):10006-14. PubMed ID: 9254595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain.
    de Mol NJ; Catalina MI; Fischer MJ; Broutin I; Maier CS; Heck AJ
    Biochim Biophys Acta; 2004 Jul; 1700(1):53-64. PubMed ID: 15210125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.